Variables
Age, years 63.9 ± 7.9
PSA, ng/dL 6.49 (4.7-9.5)
Prostate volume, ml 45 (33-62.5)
PSAD, ng/dl/ml 0.14 (0.10-0.23)
Biopsy results, n(%) Benign PCa 121 (41.7) 169 (58.3)
PI-RADS score, n (%)
II 17 (5.9)
III 77 (26.6)
IV 165 (56.9)
V 31 (10.7)
MRI lesion size, mm 9.5 (7-13)
Clinical T-stage
T1c 240 (82.8)
T2 40 (13.8)
T3 10 (3.4)
ISUP grade, n(%)
I 65 (22.4)
II 51 (17.6)
III 34 (11.7)
IV 13 (4.5)
V 6 (2.1)
RP, n(%) 53 (18.3)
Pathological T-stage, n(%) T2a T2b T2c T3a T3b 9 (17.0) 5 (7.5) 19 (35.8) 17 (32.1) 4 (7.5)
EPE, n (%) 22 (41.5)
SM, n (%) 16 (30.1)
SVI, n (%) 4 (7.5)
Lymph node metastasis, n (%) 1 (1.9)